ANGO

AngioDynamics Inc

ANGO.US angiodynamics.com
15.24
-0.08 (-0.52%)
USD · NASDAQ
52-week range
9.39
16.29
Trading at 85% of the 52-week range
Market Cap
633.21M
P/E Ratio
0.00
Forward P/E
96.15
Book Value
4.10
Div. Yield
N/A
% Institutions
94.07%
% Insiders
12.66%

1 Year

+39.3%

3 Year

+111.1%

10 Year

-5.9%
Description

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Company Information

Company Name
AngioDynamics Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US03475V1017
CIK: 0001275187
CUSIP: 03475V101
Currency: USD
Full Time Employees: 632
Phone: 518 795 1400
Fiscal Year End: May
IPO Date: May 27, 2004
Description:

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Address:

14 Plaza Drive, Latham, NY, United States, 12110

People

Directors & Officers

Name Title Year Born
Mr. James C. Clemmer CEO, President & Director 1964
Mr. Stephen A. Trowbridge Executive VP & CFO 1974
Mr. Lawrence T. Weiss Senior VP, Chief Legal Officer & Corporate Secretary 1970
Mr. Warren G. Nighan Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain 1969
Ms. Laura Piccinini Senior VP and GM of Cardiovascular & International 1969
Mr. Saleem M. Cheeks Vice President of Communications NA
Mr. Benjamin H. Davis Senior Vice President of Business Development & Strategy 1964
Ms. Marna I. Bronfen-Moore Senior Vice President of Human Resources 1968
Mr. Chad T. Campbell Senior VP and GM of Oncology & Interventional Devices 1971
Ms. Kim L. Seabury Senior Vice President of Information Technology 1968

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 21, 2025 Lawrence T Weiss N/A Purchase 10.00K $11.81 $118.10K
Oct 20, 2025 Debbie Wasserman Schultz N/A Sale N/A $11.82 N/A
Oct 13, 2025 Stephen A Trowbridge N/A Purchase 890.00 $11.16 $9.93K
Oct 09, 2025 James C Clemmer N/A Purchase 10.00K $11.15 $111.50K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.69M Mar 31, 2026 8.92% $0.00 -4.52%
Point72 Asset Management, L.P. 3.18M Mar 31, 2026 7.70% $0.05 12.61%
Systematic Financial Management LP 2.45M Mar 31, 2026 5.94% $0.64 -2.04%
Armistice Capital, LLC 1.87M Mar 31, 2026 4.52% $0.38 9.94%
Broadfin Holdings LLC 1.82M Jun 30, 2026 4.40% $100.00 -12.12%
Vanguard Capital Management, LLC 1.73M Mar 31, 2026 4.18% $0.00 0.00%
Royce & Associates, LP 1.53M Mar 31, 2026 3.70% $0.17 20.63%
Weber Capital Management LLC 1.36M Jun 30, 2026 3.28% $15.02 -1.21%
State Street Corp 1.33M Mar 31, 2026 3.23% $0.00 4.80%
Bastion Asset Management Inc. 1.31M Mar 31, 2026 3.18% $4.30 17.42%
Nuveen, LLC 1.22M Mar 31, 2026 2.94% $0.00 -6.09%
Geode Capital Management, LLC 985.42K Mar 31, 2026 2.38% $0.00 1.60%
Dimensional Fund Advisors, Inc. 969.50K Jun 30, 2026 2.35% $0.00 2.18%
Segall Bryant & Hamill 926.71K Jun 30, 2026 2.24% $0.14 -4.06%
Pier Capital, LLC 806.68K Jun 30, 2026 1.95% $1.39 1.25%
Renaissance Technologies Corp 803.28K Mar 31, 2026 1.94% $0.01 -4.72%
Millennium Management LLC 783.13K Jun 30, 2026 1.89% $0.00 21.48%
Arrowstreet Capital Limited Partnership 758.45K Mar 31, 2026 1.84% $0.00 0.73%
Paradigm Capital Management, Inc. 671.20K Jun 30, 2026 1.62% $0.24 -6.54%
Divisadero Street Capital Management, LP 562.15K Mar 31, 2026 1.36% $0.27 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.17M 2.84% ▲ 0.00% Jul 31, 2026
2 iShares Russell 2000 ETF 958.54K 2.32% ▼ 0.57% Aug 31, 2026
3 FTGF RY US SmCp Opp A USD Dis(A) 761.32K 1.84% ▲ 5.00% Jun 30, 2026
4 Royce Small-Cap Opportunity Invmt 707.40K 1.71% ▲ 10.65% Jun 30, 2026
5 CREF Total Global Stock Account R3 626.47K 1.52% ▲ 0.00% Jun 30, 2026
6 Acuitas US Microcap Strategy 498.53K 1.21% ▲ 0.00% Jun 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 485.81K 1.18% ▲ 0.25% Jul 31, 2026
8 Fidelity Small Cap Index 403.55K 0.98% ▲ 8.26% Jun 30, 2026
9 Nuveen Quant Small Cap Equity R6 382.49K 0.93% ▼ 1.94% Jun 30, 2026
10 First Eagle Small Cap Opportunity I 310.73K 0.75% ▲ 29.58% Jul 31, 2026

Financial Highlights

Market Cap: $633.21M
EBITDA: $188.00K
PEG Ratio: $1.41
Book Value: $4.10
Earnings/Share: $-0.88
Profit Margin: -11.48%
Operating Margin: -6.52%
ROA (TTM): -5.13%
ROE (TTM): -20.77%
Revenue (TTM): $320.17M
Revenue/Share (TTM): $7.71
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 8.00%

Valuation Metrics

Enterprise Value: $589.73M
Trailing P/E: 0.00
Forward P/E: 96.15

Shares Statistics

Shares Outstanding: 41.33M
Shares Float: 31.79M
% Insiders: 12.66%
% Institutions: 94.07%
Short % Float: 3.48%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$320.17M
Cost of Goods Sold
adjust
$-145.28M
Gross Profit
subtotal
$174.89M
SG&A
adjust
$-43.69M
R&D
adjust
$-29.45M
Other Operating Expense
adjust
$-141.68M
Operating Income
subtotal
$-39.93M
Other / Non-Operating Items
adjust
$3.19M
Net Income
subtotal
$-36.74M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ANGO.US!